Scleroderma is an autoimmune, rheumatic, and chronic disease that affects the body by hardening connective tissue, according to the Johns Hopkins Scleroderma Center. For the almost 500,000 people in ...

UVA researcher Blandine Baffert, working in the lab of UVA Health’s Sanja Arandjelovic and collaborating with researchers in ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

AMHERST, Va. (WDBJ) - Scleroderma is an often life-threatening inflammatory and vascular disease in which the body’s immune system attacks its own tissue. In its most aggressive form, the lungs, heart ...

SAN FRANCISCO--(BUSINESS WIRE)--The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Sanofi will contribute the first ...

Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to thicken and harden because of the overproduction of a protein called collagen.

Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology. Characterized by ...

Indero is pleased to announce a strategic collaboration with the World Scleroderma Foundation (WSF) to support WSF SHIELD platform trial, a randomized, double-blind, adaptive platform clinical trial ...

The University of Michigan John Varga Lab, in collaboration with the Mayo Clinic and Northwestern researchers, published an article last year suggesting that a heavy-chain monoclonal antibody, Ab68, ...

Utah Scleroderma Group is holding its Salt Lake City Walk and fundraiser. Utah Scleroderma Group is holding its Salt Lake City Walk and fundraiser to help with awareness, education, and research.